STERIS (NYSE:STE – Get Free Report)‘s stock had its “overweight” rating restated by stock analysts at Piper Sandler in a note issued to investors on Friday,Benzinga reports. They presently have a $275.00 target price on the medical equipment provider’s stock, up from their prior target price of $270.00. Piper Sandler’s price target indicates a potential [...]
STERIS (NYSE:STE) Earns Overweight Rating from Piper Sandler
